SCHEMBL3703305

SCHEMBL3703305

Fc1ccc(CCN2CCC(N3CCN(c4ccc(F)cc4C(F)(F)F)CC3)CC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.49
L3MBTL3 Q96JM7 6/20 0.44
L3MBTL1 Q9Y468 5/20 0.44
MBTD1 Q05BQ5 1/20 0.44
TP53BP1 Q12888 1/20 0.44
HTR2A P28223 2/20 0.43
HTR2C P28335 2/20 0.43
HTR7 P34969 2/20 0.43
ADRA1D P25100 2/20 0.43
ADRA1A P35348 2/20 0.43
ADRA1B P35368 2/20 0.43
HTR6 P50406 1/20 0.43
ALDH1A1 P00352 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3712977 0.99 MAPT (0.48) MAPTL3MBTL3L3MBTL1MBTD1TP53BP1
SCHEMBL3707936 0.84 MAPT (0.51) MAPTL3MBTL3L3MBTL1MBTD1TP53BP1
SCHEMBL3806875 0.80 MAPT (0.58) MAPTL3MBTL3L3MBTL1MBTD1TP53BP1
Hydrochloric Acid SCHEMBL3708195 0.78 MAPT (0.69) MAPTL3MBTL3L3MBTL1MBTD1TP53BP1
SCHEMBL3800379 0.76 MAPT (0.53) MAPTL3MBTL3L3MBTL1MBTD1TP53BP1
SCHEMBL3703302 0.76 OPRM1 (0.41) L3MBTL3MBTD1
Hydrochloric Acid SCHEMBL3707110 0.75 OPRM1 (0.41) L3MBTL3MBTD1
Hydrochloric Acid SCHEMBL3715814 0.74 MAPT (0.52) MAPTL3MBTL3L3MBTL1MBTD1TP53BP1
Hydrochloric Acid SCHEMBL3716255 0.73 L3MBTL3 (0.71) MAPTL3MBTL3L3MBTL1MBTD1TP53BP1
SCHEMBL13284116 0.72 PARP1 (0.47) L3MBTL3L3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010081851-A1 PIPERIDIN-4-YLPIPERAZINE COMPOUNDS FOR THE TREATMENT OF HCV INFECTION GENOSCIENCE PHARMA (FR) 2010-07-22 WO disclosed